It usually occurs when the body reacts to medications, involving skin and mucous membranes and cause serious skin rashes Toxic epidermal necrolysis (TEN) The disease can have very serious consequences and the outcome of this rare disease can lead to death.

in Germany Max Planck Institute This rare disease or its milder form is being conducted in the study by of Stevens-Johnson syndrome As a result of the treatment applied to seven patients suffering from the disease, all patients were cured. It was stated that no side effects were observed in any patient.

Hundreds of thousands are affected every year

This disease occurs worldwide one to two million per year It affects the lives of a varying number of people. The new treatment method is based on the use of drugs from the class of JAK inhibitors, which suppress the overreaction of the immune system. A patient who developed this disease during cancer treatment and lost a third of his skin recovered completely in 16 days. The risk of death for this patient was found to be 60%.

Researchers find that the underlying cause of the disease is JACK/STAT It has been found that inflammation and damage to the skin can be stopped by suppressing the so-called immune pathway. Commentary on this study Holly Anderton of the Walter and Eliza Hall Institute for Medical Research, “Being able to quickly halt the progression of the disease with this treatment will make a big difference in patient care.” he said.

Research in nature published.